Marico Share Price Today

Marico raises stake in Satiya to 84% at ₹4,200-crore valuation

Marico acquires 24.09% stake in Satiya Nutraceuticals for ₹1,012.03 crore. Aggregate holding in Satiya rises to 84.09% on fully diluted basis. Transaction implies a valuation of approximately ₹4,200 crore for Satiya. Satiya's FY26 consolidated turnover stood at ₹864.31 crore.

Marico Q2FY27 Results: Operating profit up in the mid-twenties, co likely to beat guidance

Marico expects to surpass guidance across key financial parameters. Domestic volume growth touched double digits in Q2FY27. Operating profit increased in mid-twenties percent YoY. Copra prices remained ~35% below peak levels.

Marico assigned ESG score of 76.3 by SES ESG Research

Marico received an ESG score of 76.3 from SES ESG Research Private Limited on September 23, 2026. The rating was independently determined by SES ESG, a SEBI-registered provider, without engagement by Marico. This follows a recent ESG score of 76 (Leader rating) assigned by Niche Ninety Nine on September 18, 2026. Both disclosures were made under Regulation 30 of SEBI LODR Regulations, 2015.

Marico schedules analyst meetings for September 17 and 22

Marico management to attend Jefferies India Forum on September 17. J.P. Morgan India Conference scheduled for September 22 in Mumbai. Meetings comply with SEBI LODR Regulation 30 requirements. No unpublished price-sensitive information will be shared.

Marico Latest Results: volume growth recorded, double-digit expansion expected

Marico reported an increase in volumes in the period under review. The company anticipates double-digit growth in upcoming quarters. Disclosures were made via a management interview.

Marico schedules analyst and investor meetings on September 7 and 8

Marico has planned analyst and investor meetings on September 7 and 8. The meetings are intended to facilitate engagement between the company and the investment community. No additional financial details or agenda specifics have been disclosed.